Literature DB >> 12654827

Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response.

Chun Li An1, Francis Gigliotti, Allen G Harmsen.   

Abstract

There has been emerging evidence that immunocompetent hosts can harbor Pneumocystis in their lungs. The purpose of this study was to determine the kinetics of Pneumocystis carinii f. sp. muris infection in adult immunocompetent mice and the host immune response to the organisms. To accomplish this, we exposed adult immunocompetent mice to SCID mice infected with P. carinii f. sp. muris by cohousing. We found that P. carinii f. sp. muris was detectable in the lungs of cohoused immunocompetent mice by PCR by 3 weeks after the beginning of cohousing. At about 4 weeks of cohousing, P. carinii f. sp. muris was readily detectable in the lungs of mice by microscopic techniques. Also at this time, P. carinii f. sp. muris-specific immunoglobulin G was found in the sera of the mice, and CD62(low) CD4- and CD8-positve T cells accumulated in the lungs. Shortly after this immune response, the P. carinii f. sp. muris organisms were cleared from the lungs. Adult mice cohoused for only 1 week also contained P. carinii f. sp. muris cysts detectable by silver staining at 5 and 6 weeks after the beginning of cohousing. We also found that the P. carinii f. sp. muris organisms grew to greater numbers in the lungs of BALB/c mice than in those of C57BL6 mice. This indicates that immunocompetent hosts develop a mild infection with P. carinii f. sp. muris which resolves in 5 to 6 weeks when there is a detectable immune response to the organism. Once an acquired immune response was initiated, the P. carinii f. sp. muris organisms were quickly eliminated without clinical signs of disease.

Entities:  

Mesh:

Year:  2003        PMID: 12654827      PMCID: PMC152044          DOI: 10.1128/IAI.71.4.2065-2070.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants.

Authors:  S L Vargas; W T Hughes; M E Santolaya; A V Ulloa; C A Ponce; C E Cabrera; F Cumsille; F Gigliotti
Journal:  Clin Infect Dis       Date:  2001-03-09       Impact factor: 9.079

2.  Identification of Pneumocystis carinii in the lungs of infants dying of sudden infant death syndrome.

Authors:  D J Morgan; S L Vargas; M Reyes-Mugica; J N Walterspiel; W Carver; F Gigliotti
Journal:  Pediatr Infect Dis J       Date:  2001-03       Impact factor: 2.129

3.  Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers.

Authors:  S L Vargas; C A Ponce; F Gigliotti; A V Ulloa; S Prieto; M P Muñoz; W T Hughes
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

4.  Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults.

Authors:  B A Garvy; A G Harmsen
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice.

Authors:  T W Wright; C J Johnston; A G Harmsen; J N Finkelstein
Journal:  Am J Respir Cell Mol Biol       Date:  1997-10       Impact factor: 6.914

6.  Association of primary Pneumocystis carinii infection and sudden infant death syndrome.

Authors:  S L Vargas; C A Ponce; W T Hughes; A E Wakefield; J C Weitz; S Donoso; A V Ulloa; P Madrid; S Gould; J J Latorre; R Avila; S Benveniste; M Gallo; J Belletti; R Lopez
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

7.  Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts.

Authors:  A Dumoulin; E Mazars; N Seguy; D Gargallo-Viola; S Vargas; J C Cailliez; E M Aliouat; A E Wakefield; E Dei-Cas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-09       Impact factor: 3.267

8.  Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs.

Authors:  Crystal R Icenhour; Sandra L Rebholz; Margaret S Collins; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2002-06

9.  Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses.

Authors:  B A Garvy; J A Wiley; F Gigliotti; A G Harmsen
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

10.  Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation.

Authors:  T W Wright; C J Johnston; A G Harmsen; J N Finkelstein
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

View more
  29 in total

1.  Clearance of Pneumocystis murina infection is not dependent on MyD88.

Authors:  Chiara Ripamonti; Lisa R Bishop; Jun Yang; Richard A Lempicki; Joseph A Kovacs
Journal:  Microbes Infect       Date:  2014-03-25       Impact factor: 2.700

2.  Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.

Authors:  Samir P Bhagwat; Francis Gigliotti; Haodong Xu; Terry W Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

3.  Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons.

Authors:  Anna A Shvedova; Naveena Yanamala; Elena R Kisin; Alexey V Tkach; Ashley R Murray; Ann Hubbs; Madalina M Chirila; Phouthone Keohavong; Lyudmila P Sycheva; Valerian E Kagan; Vincent Castranova
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

Review 4.  Infections in the immunosuppressed host.

Authors:  M Patricia George; Henry Masur; Karen A Norris; Scott M Palmer; Cornelius J Clancy; John F McDyer
Journal:  Ann Am Thorac Soc       Date:  2014-08

Review 5.  The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Authors:  Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2013-09-03       Impact factor: 3.346

6.  Neither classical nor alternative macrophage activation is required for Pneumocystis clearance during immune reconstitution inflammatory syndrome.

Authors:  Zhuo-Qian Zhang; Jing Wang; Zachary Hoy; Achsah Keegan; Samir Bhagwat; Francis Gigliotti; Terry W Wright
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

7.  Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.

Authors:  Hans Henrik Larsen; Marie-Louise von Linstow; Bettina Lundgren; Birthe Høgh; Henrik Westh; Jens D Lundgren
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

8.  Epidemiology of Pneumocystis colonization in families.

Authors:  LaShonda Spencer; Michelle Ukwu; Travis Alexander; Karri Valadez; Lora Liu; Toni Frederick; Andrea Kovacs; Alison Morris
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

9.  Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice.

Authors:  Paul J Christensen; Angela M Preston; Tony Ling; Ming Du; W Bradley Fields; Jeffrey L Curtis; James M Beck
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

10.  Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and rt-PCR data demonstrate active replication.

Authors:  M Chabé; E Dei-Cas; C Creusy; L Fleurisse; N Respaldiza; D Camus; I Durand-Joly
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.